Made in China Pioneers Cutting-Edge Medical Technology Redefining Precision Diagnosis & Treatment

Riding the tide of medical innovation, WeMad Medical has cemented its industry leadership through groundbreaking achievements. The 2025 Future Medical Top 100 rankings, unveiled on May 9, witnessed the company's dual triumph:

TOP100 China's Cutting-Edge Medical Devices & Intelligent Manufacturing List (Corporate Award)

Best MedTech Innovation - Intelligent Interventional Robotics (Product Award: WeMed Medical Robot DSA)

This strategic double victory underscores WeMed Medical technological prowess in redefining precision healthcare.

The Future Healthcare Top 100 stands as China's premier evaluation framework for medical innovation. Through its rigorously developed assessment methodology - integrating authoritative valuation standards and objective innovation metrics - this initiative identifies and honors trailblazing innovators shaping the future of healthcare.

Having evolved over nine years of strategic refinement, the program now serves as a comprehensive global evaluation ecosystem. Its multidimensional analysis spans:

- Enterprise innovation capabilities

- Investment portfolio impact

- Clinical institution partnerships

- Industrial park synergies

Recognized by leading international media, policymakers, and healthcare stakeholders, the Top 100 has become a critical indicator of transformative medical advancements.

It is no coincidence that Robot Medical stood out in such a highly anticipated selection. Its interventional robot, Robot DSA, is undoubtedly one of the key highlights of the award. This innovative product represents the advanced level of current intelligent medical devices.

In traditional interventional surgery, doctors need to be exposed to X-ray radiation for a long time, and slight hand shaking may affect the precise placement of vascular stents. Complex cases test the surgeon's physical strength and experience limits. The Robot DSA, an interventional robot developed by WeMed Medical, takes the "Eye-Hand-Brain" collaborative intervention solution as its core, and builds an innovative system covering the entire process of imaging, operation, and decision-making. It completely changes this dilemma with its "sub-millimeter" operation accuracy and "zero radiation" surgical environment.

Eye-Hand-Brain solution

It is like a doctor's assistant with a "super-stable robotic arm" and an "AI brain". It can complete cross-regional surgeries through 5G remote control, allowing patients in remote areas to enjoy top expert resources; intelligent bionic technology can deeply learn and imitate the techniques of experts during surgery, making surgical operations simple and standardized; the unique force feedback system has a minimum force perception accuracy of 0.01N, which can simulate the touch of real surgery, allowing doctors to "know what is going on" while operating remotely. It is worth mentioning that it is also the world's first domestically produced interventional robot with force feedback function to be launched on the market.

Clinical data is the best proof of technical strength. In hundreds of clinical trials completed by Robot DSA, the interventional robot of WeMed Medical, in multiple tertiary hospitals, the surgical success rate was as high as 100%, the incidence of major adverse cardiovascular events (MACE) within 30 days after surgery was 0, and the proportion of medium and high difficulty surgeries was nearly 90%, covering complex lesion treatment, precise stent placement and other advanced procedures, truly realizing the medical vision of "zero radiation, zero error, and zero fatigue".

In 2021, Professor Zhou Yujie's team at Beijing Anzhen Hospital affiliated to Capital Medical University used the robot to complete China's first domestically produced robotic PCI surgery without wearing lead clothing throughout the process, verifying its safety and reliability.

The Robot DSA

Standing at the forefront of the "14th Five-Year Plan" medical equipment industry planning, WeMed Medical's double awards come at the right time. The Robot DSA won the annual intelligent technology innovation product, which not only represents that the "bottleneck" high-end medical technology is being broken one by one by China's smart manufacturing, but also shows that domestic high-end medical equipment is leading the international development with "AI+interventional robots".

After ten years of hard work in the field of minimally invasive intervention, WeMed Medical has moved from "following" to "leading" - when the global medical industry is still discussing "domestic substitution", WeMed Medical has used the Robot DSA's precise surgical control, AI empowerment and deep integration with clinical scenarios, providing a new answer to "Made in China" to rewrite precision diagnosis and treatment.

You Might Also Like

Send Inquiry